Literature DB >> 15613812

Changes in orexin-A and neuropeptide Y expression in the hypothalamus of the fasted and high-fat diet fed rats.

Eun Sung Park1, Seong Joon Yi, Jin Sang Kim, Heungshik S Lee, In Se Lee, Je Kyung Seong, Hee Kyung Jin, Yeo Sung Yoon.   

Abstract

This study was aimed to investigate the changes of orexin-A (OXA) and neuropeptide Y (NPY) expression in the hypothalamus of the fasted and high-fat diet fed rats. For the experiments, the male Sprague-Dawley (SD) rats were used as the model of high-fat diet-induced obesity. The mean loss of body weight (MLBW) did not show the linear pattern during the fasting; from 24 h to 84 h of fastings, the MLBW was not significantly changed. The numbers of OXA-immunoreactive (IR) neurons were decreased at 84 h of fasting compared with those in other five fasting subgroups. The NPY immunoreactivities in the arcuate nucleus (ARC) and the suprachiasmatic nucleus (SCN) observed at 84 h of fasting were higher than that observed at 24 h of fasting. The number of OXA-IR neurons of the LHA (lateral hypothalamic area) in the high-fat (HF) diet fed group was more increased than that of the same area in the normal-fat (NF) diet fed group. The NPY immunoreactivities of the ARC and the SCN were higher in HF group than those observed in the same areas of NF group. Based on these results, it is noteworthy that the decrease of the body weight during the fast was not proportionate to the time-course, implicating a possible adaptation of the body for survival against starvation. The HF diet might activate the OXA and the NPY in the LHA to enhance food intake.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15613812

Source DB:  PubMed          Journal:  J Vet Sci        ISSN: 1229-845X            Impact factor:   1.672


  15 in total

Review 1.  Overconsumption of dietary fat and alcohol: mechanisms involving lipids and hypothalamic peptides.

Authors:  Sarah F Leibowitz
Journal:  Physiol Behav       Date:  2007-03-30

Review 2.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

Review 3.  Orexin/Hypocretin System: Role in Food and Drug Overconsumption.

Authors:  Jessica R Barson; Sarah F Leibowitz
Journal:  Int Rev Neurobiol       Date:  2017-08-08       Impact factor: 3.230

4.  Effect of dietary fatty acid composition on food intake, triglycerides, and hypothalamic peptides.

Authors:  Jessica R Barson; Olga Karatayev; Valeriya Gaysinskaya; Guo-Qing Chang; Sarah F Leibowitz
Journal:  Regul Pept       Date:  2011-09-06

Review 5.  Similarities in hypothalamic and mesocorticolimbic circuits regulating the overconsumption of food and alcohol.

Authors:  Jessica R Barson; Irene Morganstern; Sarah F Leibowitz
Journal:  Physiol Behav       Date:  2011-05-01

6.  The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task.

Authors:  Joost Wiskerke; Morgan H James; Gary Aston-Jones
Journal:  Brain Res       Date:  2019-04-16       Impact factor: 3.252

Review 7.  Advances in the neurobiological bases for food 'liking' versus 'wanting'.

Authors:  D C Castro; K C Berridge
Journal:  Physiol Behav       Date:  2014-05-27

8.  Sleep is increased by weight gain and decreased by weight loss in mice.

Authors:  Zhiwei Guan; Alexandros N Vgontzas; Edward O Bixler; Jidong Fang
Journal:  Sleep       Date:  2008-05       Impact factor: 5.849

9.  Delta FosB-mediated alterations in dopamine signaling are normalized by a palatable high-fat diet.

Authors:  Sarah L Teegarden; Eric J Nestler; Tracy L Bale
Journal:  Biol Psychiatry       Date:  2008-07-26       Impact factor: 13.382

10.  Effect of high-fat feeding on expression of genes controlling availability of dopamine in mouse hypothalamus.

Authors:  Alex K Lee; Marjan Mojtahed-Jaberi; Theodosios Kyriakou; Estibaliz Aldecoa-Otalora Astarloa; Matthew Arno; Nichola J Marshall; Susan D Brain; Sandra D O'Dell
Journal:  Nutrition       Date:  2009-10-06       Impact factor: 4.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.